Although lowering side effects plays an important role in oral contraceptive compliance, one of the biggest challenges for patients is adhering to the daily schedule of the pill. Forgetting one to three pills per cycle is a frequent problem among 15-51% of users, particularly among adolescents. Lyndra Therapeutics has received a $13 million grant from the Bill & Melinda Gates Foundation and is setting out to remove the daily pill compliance challenge. The company is in early development of a monthly oral contraceptive to provide women with a discreet, noninvasive, reversible contraception option.

In this retrospective cohort study of 279 women undergoing postpartum partial salpingectomy after vaginal delivery, the mean operative time for women with a BMI ≥ 30 kg/m² was only 5.5 minutes longer than the time for women with a BMI < 30 kg/m².

Combined oral contraceptives have been shown to provide health benefits beyond birth control.

In 2002, just 2.4% of U.S. women using birth control were using long-acting reversible contraceptive (LARC) methods, such as the intrauterine device or the contraceptive implant. By 2014, about 14% of women using birth control reported LARC use.

In a pooled analysis of prospective studies, researchers found an increased risk of breast cancer among parous women that persists for more than 20 years after childbirth. Breastfeeding did not modify this pattern.

In this secondary analysis of the Contraceptive CHOICE Project, there was no difference in copper intrauterine device continuation rates at one year between 165 women who reported heavy menstrual bleeding at baseline and 753 women who did not.